A student development evening was held again this year on 26 August 2019 at Monash University Clayton where Professor Graham Jenkin (Cartherics’ Education Officer) represented us. More on our PhD projects on our Education Opportunities page.
Drugs work stunningly well to control HIV—but not in everyone, and not without side effects. That’s why a small cadre of patients known as elite controllers has long fascinated researchers: Their immune system alone naturally suppresses HIV for decades without drugs. Now one team, inspired by success in mice, hopes to endow HIV-infected people […]
Despite the recent […]
https://www.premier.vic.gov.au/car-t-cell-cancer-therapy-to-save-lives/
The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients
The Victorian and Commonwealth Governments have worked together to bring the revolutionary, life-saving new […]
The Age, 28 July 2019
By Melissa Cunningham
Former SeaChange actor Tom Long was on the brink of death when he boarded a flight to the United States in April to take part in a medical trial for terminal blood cancer.
He arrived in Seattle with sunken cheeks and a body ravaged by chemotherapy. Weighing a little more […]
As of July, the number of scientists sharing the work load in Cartherics’ laboratory hit an even dozen. That’s thanks to Research Fellow and haematologist Madeline Cao who joined the team from CSIRO where she worked on haematopoietic stem cells with Susie Nilsson’s group.
At Cartherics her focus is […]
STAT Biotech – By Sharon Begley @sxbegle
JUNE 25, 2019
The U.S. patent office has declared an interference between a dozen key patents awarded to the Broad Institute on the genome-editing technology CRISPR and 10 CRISPR patent applications submitted by the University of California and its partners, according to documents posted by the U.S. Patent and […]
Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited, Freehills, Amrad, Meditech, Daratech, Australian Stem Cell Centre, TGR Biosciences, and two Cooperative Research Centres.
Based on his depth of […]
MEDIA RELEASE
8 May 2019 Parties use science to set themselves apart ….
The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.
Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd